Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX) -- Ignore unavailable to you. Want to Upgrade?

To: software salesperson who wrote (1480)	1/12/2006 11:42:21 AM
From: NeuroInvestment	Respond to of 1834

<< i wonder if the pfe ad policy speculation might be true.>> If you are referring to abstinence from DTC for six months, it is true. When asked about this yesterday at the break-out, Lyons said that (and there were Pfizer people in the room) this would not necessarily reduce PFE marketing expenditures, but reallocate them to 'prescriber education'. I personally am hoping that Pfizer will set up prescriber 're-education camps' in Fiji or Maui, so that prescribers--and newsletter publishers-- can be fully oriented to indiplon in a setting favorable to cognitive transformation. Harry NeuroInvestment